MENU
+Compare
CTSO
Stock ticker: NASDAQ
AS OF
Apr 25, 10:51 AM (EDT)
Price
$1.10
Change
-$0.06 (-5.17%)
Capitalization
49.22M

CTSO Cytosorbents Corp Forecast, Technical & Fundamental Analysis

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology... Show more

CTSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CTSO with price predictions
Apr 24, 2025

CTSO's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CTSO turned positive on April 15, 2025. Looking at past instances where CTSO's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 15, 2025. You may want to consider a long position or call options on CTSO as a result. In of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CTSO moved above its 50-day moving average on April 21, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CTSO advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for CTSO crossed bearishly below the 50-day moving average on March 27, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTSO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CTSO broke above its upper Bollinger Band on April 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CTSO entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.115) is normal, around the industry mean (23.728). P/E Ratio (0.000) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.302) is also within normal values, averaging (41.794).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CTSO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTSO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
CTSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CTSO is expected to report earnings to rise 66.67% to -5 cents per share on May 06

Cytosorbents Corp CTSO Stock Earnings Reports
Q1'25
Est.
$-0.05
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.02
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.01
The last earnings report on March 31 showed earnings per share of -2 cents, beating the estimate of -5 cents. With 2.12K shares outstanding, the current market capitalization sits at 49.22M.
A.I. Advisor
published General Information

General Information

a developer of products to support healthcare professionals in the treatment of complex medical conditions

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
305 College Road East
Phone
+1 732 329-8885
Employees
186
Web
https://www.cytosorbents.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESI20.531.31
+6.82%
Element Solutions
HRTX2.270.07
+3.18%
Heron Therapeutics
EFSC51.590.84
+1.66%
Enterprise Financial Services Corp
INUV0.39N/A
+1.06%
Inuvo
EQIX817.197.73
+0.95%
Equinix

CTSO and Stocks

Correlation & Price change

A.I.dvisor tells us that CTSO and RBOT have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTSO and RBOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTSO
1D Price
Change %
CTSO100%
+8.41%
RBOT - CTSO
27%
Poorly correlated
+20.69%
LUNG - CTSO
25%
Poorly correlated
+3.61%
NNOX - CTSO
25%
Poorly correlated
+4.31%
CORBF - CTSO
24%
Poorly correlated
+10.53%
AZTA - CTSO
23%
Poorly correlated
+5.16%
More